These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6607329)

  • 1. Dosing implications of rapid elimination of trimethoprim-sulfamethoxazole in patients with cystic fibrosis.
    Reed MD; Stern RC; Bertino JS; Myers CM; Yamashita TS; Blumer JL
    J Pediatr; 1984 Feb; 104(2):303-7. PubMed ID: 6607329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
    Nissenson AR; Wilson C; Holazo A
    Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous pharmacokinetics and in vitro bactericidal activity of trimethoprim-sulfamethoxazole.
    Spicehandler J; Pollock AA; Simberkoff MS; Rahal JJ
    Rev Infect Dis; 1982; 4(2):562-5. PubMed ID: 6981172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.
    Brown MP; Gronwall R; Castro L
    Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.
    Siber GR; Gorham CC; Ericson JF; Smith AL
    Rev Infect Dis; 1982; 4(2):566-78. PubMed ID: 6981173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of trimethoprim-sulfamethoxazole in newborn infants.
    Springer C; Eyal F; Michel J
    J Pediatr; 1982 Apr; 100(4):647-50. PubMed ID: 7062219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of sulfamethoxazole and trimethoprim association in hens.
    Queralt J; Castells I
    Poult Sci; 1985 Dec; 64(12):2362-7. PubMed ID: 4095069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral or intravenous trimethoprim-sulfamethoxazole therapy for shigellosis.
    Nelson JD; Kusmiesz H; Shelton S
    Rev Infect Dis; 1982; 4(2):546-50. PubMed ID: 6981170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tolerance of a single twelve-tablet dose of trimethoprim (960 mg)-sulfamethoxazole (4,800 mg).
    Fass RJ; Prior RB; Perkins RL
    Antimicrob Agents Chemother; 1977 Jul; 12(1):102-6. PubMed ID: 883811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of pharmacokinetics of the combination trimethoprim and sulfamethoxazole in patients with liver diseases and healthy persons].
    Rieder VJ; Schwartz DE
    Arzneimittelforschung; 1975 Apr; 25(4):656-66. PubMed ID: 1174084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of trimethoprim-sulfamethoxazole in the treatment of chest infections.
    Hughes DT; Russell NJ
    Rev Infect Dis; 1982; 4(2):528-32. PubMed ID: 7051245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state pharmacokinetics of sulfamethoxazole and trimethorprim in man after rectal application.
    Liedtke R; Haase W
    Arzneimittelforschung; 1979; 29(2):345-9. PubMed ID: 582148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of trimethoprim-sulfamethoxazole in blood after a single, large oral dose.
    Yoshikawa TT; Guze LB
    Antimicrob Agents Chemother; 1976 Sep; 10(3):462-3. PubMed ID: 984788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single and multiple dose kinetics of co-tetroxazine and co-trimoxazole in patients.
    Vergin H; Ferber H; Zimmermann I; Neurath GB
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):350-7. PubMed ID: 6975762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the trimethoprim-sulphamethoxazole combination in the elderly.
    Varoquaux O; Lajoie D; Gobert C; Cordonnier P; Ducreuzet C; Pays M; Advenier C
    Br J Clin Pharmacol; 1985 Dec; 20(6):575-81. PubMed ID: 3879182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung tissue diffusion of intravenous trimethoprim-sulfamethoxazole combination (author's transl)].
    Morel C; Langeard M; Vergnaud M; Monrocq N
    Pathol Biol (Paris); 1982 Jun; 30(6):380-4. PubMed ID: 7050846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE; Blevins RB; Salem NG; Matzke GR
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
    Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
    J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole.
    Grose WE; Bodey GP; Loo TL
    Antimicrob Agents Chemother; 1979 Mar; 15(3):447-51. PubMed ID: 464572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.
    Singlas E; Colin JN; Rottembourg J; Meessen JP; de Martin A; Legrain M; Simon P
    Eur J Clin Pharmacol; 1982; 21(5):409-15. PubMed ID: 7075646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.